Modeling of ligand binding to G protein coupled receptors: cannabinoid CB1, CB2 and adrenergic β2AR

被引:0
|
作者
Dorota Latek
Michal Kolinski
Umesh Ghoshdastider
Aleksander Debinski
Rafal Bombolewski
Anita Plazinska
Krzysztof Jozwiak
Slawomir Filipek
机构
[1] University of Warsaw,Faculty of Chemistry
[2] Medical University of Lublin,Department of Chemistry
[3] Goethe-University of Frankfurt/Main,Centre for Biomolecular Magnetic Resonance, Institute for Biophysical Chemistry
[4] University of Warsaw,Faculty of Physics
[5] International Institute of Molecular and Cell Biology,undefined
来源
关键词
Cannabinoid receptors; Docking; Fenoterol; GPCRs; Molecular dynamics; Molecular switches;
D O I
暂无
中图分类号
学科分类号
摘要
Cannabinoid and adrenergic receptors belong to the class A (similar to rhodopsin) G protein coupled receptors. Docking of agonists and antagonists to CB1 and CB2 cannabinoid receptors revealed the importance of a centrally located rotamer toggle switch and its possible participation in the mechanism of agonist/antagonist recognition. The switch is composed of two residues, F3.36 and W6.48, located on opposite transmembrane helices TM3 and TM6 in the central part of the membranous domain of cannabinoid receptors. The CB1 and CB2 receptor models were constructed based on the adenosine A2A receptor template. The two best scored conformations of each receptor were used for the docking procedure. In all poses (ligand-receptor conformations) characterized by the lowest ligand-receptor intermolecular energy and free energy of binding the ligand type matched the state of the rotamer toggle switch: antagonists maintained an inactive state of the switch, whereas agonists changed it. In case of agonists of β2AR, the (R,R) and (S,S) stereoisomers of fenoterol, the molecular dynamics simulations provided evidence of different binding modes while preserving the same average position of ligands in the binding site. The (S,S) isomer was much more labile in the binding site and only one stable hydrogen bond was created. Such dynamical binding modes may also be valid for ligands of cannabinoid receptors because of the hydrophobic nature of their ligand-receptor interactions. However, only very long molecular dynamics simulations could verify the validity of such binding modes and how they affect the process of activation.
引用
收藏
页码:2353 / 2366
页数:13
相关论文
共 50 条
  • [1] Modeling of ligand binding to G protein coupled receptors: cannabinoid CB1, CB2 and adrenergic β2AR
    Latek, Dorota
    Kolinski, Michal
    Ghoshdastider, Umesh
    Debinski, Aleksander
    Bombolewski, Rafal
    Plazinska, Anita
    Jozwiak, Krzysztof
    Filipek, Slawomir
    JOURNAL OF MOLECULAR MODELING, 2011, 17 (09) : 2353 - 2366
  • [2] Binding thermodynamics at the human cannabinoid CB1 and CB2 receptors
    Merighi, Stefania
    Simioni, Carolina
    Gessi, Stefania
    Varani, Katia
    Borea, Pier Andrea
    BIOCHEMICAL PHARMACOLOGY, 2010, 79 (03) : 471 - 477
  • [3] Characterization of structural requirements for ligand binding to the CB1 and CB2 cannabinoid receptors.
    Berglund, BA
    Fleming, PR
    Rice, K
    Howlett, AC
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1998, 358 (01) : R726 - R726
  • [4] Pharmacology of cannabinoid CB1 and CB2 receptors
    Pertwee, RG
    PHARMACOLOGY & THERAPEUTICS, 1997, 74 (02) : 129 - 180
  • [5] Anterior segment CB1 and CB2 cannabinoid receptors
    Song, ZH
    Jiang, J
    Hemesath, A
    McCloud, C
    Zhong, L
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2002, 43 : U1157 - U1157
  • [6] Agonist selective regulation of g proteins by cannabinoid CB1 and CB2 receptors
    Glass, M
    Northup, JK
    MOLECULAR PHARMACOLOGY, 1999, 56 (06) : 1362 - 1369
  • [7] Structural and functional insights into the G protein-coupled receptors: CB1 and CB2
    Brust, Christina A.
    Swanson, Matthew A.
    Bohn, Laura M.
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2023, 51 (04) : 1533 - 1543
  • [8] Ligand-ligand and ligand-receptor approaches to modeling the cannabinoid CB1 and CB2 receptors:: Achievements and challenges
    Reggio, PH
    CURRENT MEDICINAL CHEMISTRY, 1999, 6 (08) : 665 - 683
  • [9] Novel cannabinol probes for CB1 and CB2 cannabinoid receptors
    Mahadevan, A
    Siegel, C
    Martin, BR
    Abood, ME
    Beletskaya, I
    Razdan, RK
    JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (20) : 3778 - 3785
  • [10] CB1 and CB2 cannabinoid receptors are implicated in inflammatory pain
    Clayton, N
    Marshall, FH
    Bountra, C
    O'Shaughnessy, CT
    PAIN, 2002, 96 (03) : 253 - 260